Milan, Italy

Natale Barbugian


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1989-1993

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Natale Barbugian: Innovator in Pharmaceutical Chemistry

Introduction

Natale Barbugian is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 4 patents, Barbugian's work has had a meaningful impact on the treatment of hormone-dependent cancers.

Latest Patents

Barbugian's latest patents include a process for the preparation of 4-amino-unsaturated androstanedione derivatives. These compounds exhibit aromatase inhibitory activity, which is crucial for therapeutic applications. Another significant invention involves the development of 6-alkylidenandrosta-1,4-diene-3,17-dione derivatives. These derivatives are characterized by their general formula, where each of R and R2 can be hydrogen or C1-C6 alkyl, and R1 can be hydrogen, halogen, or C1-C6 alkyl. These compounds are particularly useful in the treatment of hormone-dependent cancers.

Career Highlights

Throughout his career, Natale Barbugian has worked with prominent companies in the pharmaceutical industry, including Farmitalia Carlo Erba S.r.l. and Farmitalia Carlo Erba S.p.a. His work in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Barbugian has collaborated with esteemed colleagues such as Franco Buzzetti and Paolo Lombardi. These partnerships have fostered a collaborative environment that has led to the advancement of pharmaceutical research and development.

Conclusion

In summary, Natale Barbugian is a distinguished inventor whose work in pharmaceutical chemistry has resulted in valuable patents and collaborations. His contributions continue to influence the field and improve therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…